Unknown

Dataset Information

0

Computational study on novel natural compound inhibitor targeting IDH1_R132H.


ABSTRACT: Isocitrate dehydrogenases (IDH) catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. IDH1 mutation has been reported in various tumors especially Cholangiocarcinoma, while the IDH1_R132H is reported to be the most common mutation of IDH1. IDH1_R132H inhibitors are effective anti-cancer drugs and have shown significant therapeutic effects in clinical. In this study, two novel natural compounds were identified to combine respectively with IDH1_R132H with a stronger binding force with conductive to interaction energy. They also showed low toxicity potential. Molecular dynamics simulation analysis demonstrated that the candidate ligands-IDH1_R132H complexes is stable in natural circumstances with favorable potential energy. Thus, Styraxlignolide F and Tremulacin were screened as promising IDH1_R132H inhibitors. We provide a solid foundation for the design and development of IDH1_R132H targeted drugs.

SUBMITTER: Zhou B 

PROVIDER: S-EPMC9320544 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8280014 | biostudies-literature
| S-EPMC7244087 | biostudies-literature
| S-EPMC8266345 | biostudies-literature
| S-EPMC4813202 | biostudies-literature
| S-EPMC7738058 | biostudies-literature
| S-EPMC7343476 | biostudies-literature
| S-EPMC9217697 | biostudies-literature
| S-EPMC6532845 | biostudies-literature
| S-EPMC7880371 | biostudies-literature
| S-EPMC3691947 | biostudies-literature